company_name,website_timestamp,preclinical_stage,drug_molecule,target,therapeutic_area,target_type,development_stage,small_molecules,small_molecules_keyword,small_molecules_source_url,peptides,peptides_keyword,peptides_source_url,proteins,proteins_keyword,proteins_source_url,antibodies,antibodies_keyword,antibodies_source_url,antibody_conjugates,antibody_conjugates_keyword,antibody_conjugates_source_url,fusion_proteins,fusion_proteins_keyword,fusion_proteins_source_url,nucleic_acid_therapeutics,nucleic_acid_therapeutics_keyword,nucleic_acid_therapeutics_source_url,gene_cell_therapies,gene_cell_therapies_keyword,gene_cell_therapies_source_url,vaccines,vaccines_keyword,vaccines_source_url,protein_degraders,protein_degraders_keyword,protein_degraders_source_url,other_modalities,other_modalities_keyword,other_modalities_source_url
aurigene oncology,Error: can't compare offset-naive and offset-aware dateti,Yes,Not specified,Not specified,oncology,Not specified,Preclinical,Yes,Small Molecules,https://www.ambitionbox.com/overview/aurigene-discovery-technologies-overview,Yes,Peptides and Peptidomimetics,https://www.ambitionbox.com/overview/aurigene-discovery-technologies-overview,No,,,Yes,Antibodies,https://www.ambitionbox.com/overview/aurigene-discovery-technologies-overview,No,,,No,,,No,,,Yes,CAR-T cell therapy,https://www.aurigene.com/,No,,,Yes,Targeted protein Degradation,https://www.ambitionbox.com/overview/aurigene-discovery-technologies-overview,No,,
bharat biotech,16-10-2025 06:32,Yes,iNCOVACC,"SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2",infectious diseases,other,Approved,No,,,No,,,Yes,"India’s first recombinant Epidermal Growth Factor (REGEN-D®) to combat diabetic foot ulcers, burns",https://dcvmn.org/member/bharat/,No,,,No,,,No,,,No,,,No,,,Yes,"ROTAVAC, TypbarTCV, Biopolio, Comvac, JENVAC, COVAXIN",https://en.wikipedia.org/wiki/Bharat_Biotech,No,,,No,,
23 century clinic,16-10-2025 05:36,No,RNDP-001,"Disease Name, Parkinson’s Disease",CNS,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,stem cell therapy,https://23cbio.com/,No,,,No,,,Yes,Advanced immune cell therapy technology,https://23chealthcare.com/about-us/
nexcella inc,"Error: Connection failed - HTTPSConnectionPool(host='www.cirm.ca.gov', port=4",No,NXC-201,"BCMA, B-cell Maturation Antigen",oncology,immune checkpoint,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR-T cell therapy,https://www.cgtlive.com/view/immix-nexcella-make-progress-us-trial-light-chain-amyloidosis-car-t-nxc-201,No,,,No,,,No,,
targazyme inc,10-10-2023 06:40,No,TZ 101,Not specified,oncology,enzyme,Phase 3,Yes,small molecule products (TZ101 and TZ102),https://www.linkedin.com/company/targazyme,No,,,Yes,clinical-grade fucosyltransferase enzymes,https://www.linkedin.com/company/targazyme,No,,,No,,,No,,,No,,,Yes,gene therapy and regenerative medicine,https://www.linkedin.com/company/targazyme,No,,,No,,,Yes,"cell therapy, immunotherapies for autoimmune diseases and cancer, stem cell transplantation",https://www.linkedin.com/company/targazyme
shenzhen pregene biopharma co ltd,06-04-2022 08:30,Yes,Not specified,"CD19/CD22, Cluster of Differentiation 19/Cluster of Differentiation 22",oncology,other,Preclinical,No,,,No,,,No,,,Yes,Nanobody Screening Platform,http://en.pregene.com/,No,,,No,,,No,,,Yes,Developing urgently needed cell and gene therapy drugs for clinical treatment,http://en.pregene.com/,No,,,No,,,No,,
biotherapy services ltd,24-09-2025 00:00,No,ZORYVE,"PDE4, Phosphodiesterase 4",dermatology,enzyme,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,regenerative medicine for the treatment of complex wounds,https://www.foresight.group/news/innovative-biopharmaceutical-company-biotherapy-services-ltd-secures-30-million-investment-from-foresight,No,,,No,,,Yes,RAPID™ Biodynamic Haematogel supporting clinicians with an interest in wound care,https://www.icfg.net/transactions/biotherapy-services-ltd/
